We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TPST icon
476
Tempest Therapeutics
TPST
$13.7M
$13.7M $0.8563 0.86%
ICU icon
477
SeaStar Medical
ICU
$12.5M
$12.5M $3.13 1.57%
BLRX
478
BioLineRX
BLRX
$12.3M
$12.3M $2.82 4.44%
BCDA icon
479
BioCardia
BCDA
$12.3M
$12.3M $0.8242 6.89%
PBM icon
480
Psyence Biomedical
PBM
$12.1M
$12.1M $3.17 5.65%
PHIO icon
481
Phio Pharmaceuticals
PHIO
$11.8M
$11.8M $1.02 0.97%
BIVI icon
482
BioVie
BIVI
$11.5M
$11.5M $1.52 6.29%
CMMB
483
Chemomab Therapeutics
CMMB
$11.4M
$11.4M $1.55 1.31%
KPRX icon
484
Kiora Pharmaceuticals
KPRX
$11.3M
$11.3M $2.56 0%
COCP icon
485
Cocrystal Pharma
COCP
$11.3M
$11.3M $0.8200 5.5%
INTS icon
486
Intensity Therapeutics
INTS
$11.2M
$11.2M $4.15 2.47%
GDTC icon
487
CytoMed Therapeutics
GDTC
$11M
$11M $0.9301 5.99%
SNTI icon
488
Senti Biosciences Holdings
SNTI
$10.6M
$10.6M $0.3405 5.52%
GTBP icon
489
GT Biopharma
GTBP
$10.6M
$10.6M $0.2935 4.65%
XCUR icon
490
Exicure
XCUR
$10.2M
$10.2M $1.60 1.91%
VTGN icon
491
VistaGen Therapeutics
VTGN
$9.89M
$9.89M $0.2410 0%
INAB icon
492
IN8bio
INAB
$9.88M
$9.88M $1.03 4.63%
CRIS icon
493
Curis
CRIS
$9.78M
$9.78M $5.02 1.21%
LSTA icon
494
Lisata Therapeutics
LSTA
$9.02M
$9.02M $0.9900 3.88%
QNRX
495
Quoin Pharmaceuticals
QNRX
$8.94M
$8.94M $4.45 1.14%
IMRN
496
Immuron
IMRN
$8.8M
$8.8M $1.09 1.8%
LNAI
497
Lunai Bioworks
LNAI
$8.8M
$8.8M $1.94 3.96%
CNSP icon
498
CNS Pharmaceuticals
CNSP
$8.51M
$8.51M $5.82 20%
ASBP
499
Aspire Biopharma
ASBP
$8.44M
$8.44M $6.52 2.98%
NIKI
500
Niki BioSolutions, Inc. Common Stock
NIKI
$8.04M
$8.04M $9.87 2.95%
18 19
20
21 22

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 566 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.2T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $121B, Regeneron Pharmaceuticals (REGN) at $78.5B and argenx (ARGX) at $53.4B.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.